Greater Cannabis Company (GCAN) Equity Ratio (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Equity Ratio of 538.59 in Q1 2026, up 40.81% quarter-over-quarter from 910.0 in Q4 2025, and down 2920.65% on a YoY basis from 19.09 in Q1 2025.
Greater Cannabis Company (GCAN) Equity Ratio (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Equity Ratio history runs 10 years deep, the most recent figure standing at 538.59 for Q1 2026.
- In Q1 2026, Equity Ratio fell 2920.65% year-over-year to 538.59; the TTM figure through Mar 2026 stood at 538.59 (down 2920.65% YoY), while the FY2025 annual figure was 910.0, down 6158.0% from the prior year.
- Equity Ratio was 538.59 for Q1 2026 at Greater Cannabis Company, up from 910.0 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 1.62 in Q1 2022 to a low of 910.0 in Q4 2025.
- Historically, Equity Ratio has averaged 95.23 across 5 years, with a median of 5.29 in 2024.
- The sharpest annual moves came in 2023 and 2025: Equity Ratio decreased 28.57% in 2023, then tumbled 6158.0% in 2025.
- A 5-year view of Equity Ratio shows it stood at 1.94 in 2022, then slumped by 97.57% to 3.84 in 2023, then plunged by 278.86% to 14.54 in 2024, then sank by 6158.0% to 910.0 in 2025, then jumped by 40.81% to 538.59 in 2026.
- The last three Equity Ratio figures came in at 538.59 (Q1 2026), 910.0 (Q4 2025), and 51.9 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.21 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.21 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.88 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.73 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.69 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.49 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.41 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.52 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 0.20 |
| 10 | Greater Cannabis Company | - | - | - | -538.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -538.59 |
| Dec 31, 2025 | -910.00 |
| Sep 30, 2025 | -51.90 |
| Jun 30, 2025 | -40.14 |
| Mar 31, 2025 | -17.83 |
| Dec 31, 2024 | -14.54 |
| Sep 30, 2024 | -12.46 |
| Jun 30, 2024 | -9.02 |
| Mar 31, 2024 | -5.29 |
| Dec 31, 2023 | -3.84 |
| Sep 30, 2023 | -3.15 |
| Jun 30, 2023 | -2.55 |
| Mar 31, 2023 | -2.25 |
| Dec 31, 2022 | -1.94 |
| Sep 30, 2022 | -1.87 |
| Jun 30, 2022 | -1.98 |
| Mar 31, 2022 | -1.62 |
| Dec 31, 2021 | -1.19 |
| Sep 30, 2021 | -0.54 |
| Jun 30, 2021 | -0.15 |